Heat shock proteins enriched-promastigotes of Leishmania major inducing Th2 immune response in BALB/c mice.

Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol (1999) 9.95

A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol (1985) 4.71

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol (2003) 3.17

Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem (1996) 3.04

Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res (2000) 2.91

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med (1997) 2.81

Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev (1999) 2.69

Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem (2002) 2.06

Rodent control operations against zoonotic cutaneous leishmaniasis in rural Iran. Ann Saudi Med (2005) 1.41

The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol (2001) 1.20

Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect Immun (1995) 1.20

Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. Br Med Bull (2006) 1.18

High constitutive levels of heat-shock proteins in human-pathogenic parasites of the genus Leishmania. Biochem J (1995) 1.14

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis. Infect Immun (2005) 1.11

Structure-function analysis of the heat shock factor-binding protein reveals a protein composed solely of a highly conserved and dynamic coiled-coil trimerization domain. J Biol Chem (2001) 1.08

Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J Immunol (2004) 1.04

Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. Vaccine (2007) 0.98

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients. Vaccine (2007) 0.97

Heat shock protein vaccines: from bench to bedside. Int Rev Immunol (2006) 0.96

IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect (2007) 0.94

Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med (2003) 0.91

A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. Int Immunol (2009) 0.88

Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis. Vaccine (2005) 0.86

BCG (Bacille Calmette-Guérin) HspCs (heat-shock protein-peptide complexes) induce T-helper 1 responses and protect against live challenge in a murine aerosol challenge model of pulmonary tuberculosis. Biochem Soc Trans (2004) 0.86

Present status of antileishmanial vaccines. Mol Cell Biochem (2003) 0.84

Modulatory effects of the human heat shock protein 70 on DNA vaccination. J Biomed Sci (2000) 0.82

Peptides complexed with the protein HSP70 generate efficient human cytolytic T-lymphocyte responses. Biochem Soc Trans (2004) 0.78